Tuberculosis Prevention in Methadone Maintenance Clinics
- 1 July 1999
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 160 (1) , 178-185
- https://doi.org/10.1164/ajrccm.160.1.9810082
Abstract
To determine the effectiveness and cost-effectiveness of a program to provide screening for tuberculosis infection and directly observed preventive therapy (DOPT) in methadone maintenance clinics, we determined completion rates of screening for tuberculosis infection, medical evaluation, and preventive therapy, as well as the number of active tuberculosis cases and tuberculosis-related deaths prevented, in five clinics in San Francisco, California. Between 1990 and 1995, a total of 2,689 clients (of whom 18% were HIV-seropositive) were screened at least once. Of eligible clients, 99% received tuberculin skin tests, 96% received a medical examination, 91% began isoniazid preventive therapy, and 82% completed preventive therapy. Program effectiveness was enhanced by close collaboration between public health and methadone maintenance programs and the use of incentives and enablers. Over a 3-yr follow-up period, only one verified case of tuberculosis was reported among clients with a positive tuberculin skin test, thereby preventing as much as 95% of expected tuberculosis cases. Over 10 yr, we estimate the program would prevent 30.0 (52%) of 57.7 expected cases of tuberculosis, and 7.6 (57%) of 13.4 expected tuberculosis-related deaths. The program cost $771,569, but averted an estimated $876,229, for a net savings of $104,660 (average of $3, 724 per case prevented). Our study demonstrates that when effectively implemented, screening for tuberculosis infection and DOPT in methadone maintenance clinics is a highly cost-effective approach to prevent tuberculosis.Keywords
This publication has 21 references indexed in Scilit:
- Directly Observed Therapy for Treatment Completion of Pulmonary TuberculosisConsensus Statement of the Public Health Tuberculosis Guidelines PanelJAMA, 1998
- Incidence of Tuberculosis in Injection Drug Users in San FranciscoAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Progression of Human Immunodeficiency Virus Infection in Patients with Tuberculosis Disease: A Cohort Study in Bordeaux, France, 1988-1994American Journal of Epidemiology, 1997
- Incidence of Tuberculosis in the United States among HIV-Infected PersonsAnnals of Internal Medicine, 1997
- Successful Adherence to Observed Prophylaxis and Treatment of Tuberculosis Among Drug Users in a Methadone ProgramJournal of Addictive Diseases, 1996
- Risk Factors for Tuberculosis in HIV-lnfected PersonsJAMA, 1995
- Accelerated course of human immunodeficiency virus infection after tuberculosis.American Journal of Respiratory and Critical Care Medicine, 1995
- Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention.American Journal of Respiratory and Critical Care Medicine, 1994
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989
- The Markov Process in Medical PrognosisMedical Decision Making, 1983